Project Grant K08NS136775

Award Date 7/1/25
Completion Date 6/30/30
Dollars Obligated $224K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $385,500.00 to The Leland Stanford Junior University to develop an inducible and multiplexed CRISPR-based gene regulation system to study neuronal activity and regeneration. The key products and services to be delivered include: 1) Engineering an inducible system capable of...
The $258,342 Project Grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke will support research into the mechanisms of dendritic tiling at Stanford University. Specifically, the grant will fund two specific aims: first, to test the hypothesis that activity-dependent mechanisms result in tiling of dendrites in C. elegans using live imaging of neighboring neurons labeled with distinct fluorescent reporters; and second, to assess the impact of...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $673,189 to The Leland Stanford Junior University (Stanford University) to investigate how changes in cerebrospinal fluid (CSF) ion concentrations, particularly potassium (K+), support brain development and function. The award aims to determine how the natural shift in CSF K+ levels over development affects neural progenitor maintenance,...
This $1,341,874 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program supports research focused on understanding the molecular mechanisms that control dendrite development, mechano-sensation exhibited by Drosophila dendritic arborization (DA) neurons, and mechanisms underlying dendrite and axon regeneration after injury. The primary...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $147,656 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to The Leland Stanford Junior University (Stanford University). This 18-month grant, effective January 28, 2025, supports research to understand how flexible transformations of spatial representations in the medial entorhinal cortex (MEC) are influenced by neural circuits conveying physical versus...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $599,204 to The Leland Stanford Junior University to investigate the cellular mechanisms driving learning-induced myelin remodeling and its role in motor learning. The key objectives are to determine if oligodendrocyte calcium signaling is required for myelin sheath...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $4,101,949 to The Leland Stanford Junior University to develop innovative neuroscience tools for precisely manipulating synaptic connections between genetically- or anatomically-defined neuronal populations. The project aims to engineer three different tool platforms that enable drug-controlled, trans-synaptic manipulation of neuronal...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $2,307,075 to The Leland Stanford Junior University to conduct innovative research aimed at defining mechanisms of neurodegenerative diseases and developing therapeutic strategies. The key research efforts include: using yeast and human genetics to identify novel...
This National Institute of Neurological Disorders and Stroke (NINDS) Project Grant award under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $582,883 to the Regents of the University of California at Riverside to conduct research on the role of CAS adaptor proteins during cortical axon pathfinding. The 5-year study aims to explore how adhesive and instructive signaling pathways are integrated within neurons to guide proper brain...
This federal Project Grant award of $769,352.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program will support the development of an engineered bioprinting platform to study neural migration in brain assembloids - complex 3D models that combine distinct brain organoids to better capture regional interactions critical for neurodevelopment. The award will enable researchers at The Leland Stanford Junior University to: 1) Evaluate...

This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA Program 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders provides $223,665.00 in funding to The Leland Stanford Junior University for a research project titled "Determining How CACNA1C Variants Cause Interneuron Pathophysiology." The objective is to employ gene editing, neural organoid and assembloid models, calcium imaging, and RNA sequencing to investigate how variants in the CACNA1C gene impact interneuron migration and cortical network activity, with the goal of elucidating core pathways that could become therapeutic targets for neurodevelopmental disorders. The 5-year project will be led by Principal Investigator Dr. Rebecca Levy, a neurogeneticist, and supported by a mentorship team of experts in gene editing, calcium channel biology, systems neuroscience, and rare disease genetics. The research will be conducted at Stanford University, which has a rich environment of core facilities, seminars, and collaborations to support the work.

Generated 6/24/25, 6:23 AM